Market Exclusive

DIGIRAD CORPORATION (NASDAQ:DRAD) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

DIGIRAD CORPORATION (NASDAQ:DRAD) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Item 5.03. Amendments to Articles of Incorporation or Bylaws;
Change in Fiscal Year

On April 5, 2017, the Board of Directors of Digirad Corporation
(the “Company”) approved, and adopted effective as of such date,
an amendment (the Amendment) to its Amended and Restated Bylaws
of Digirad Corporation (the “Bylaws”). The Amendment amends
Article III Section 13 of the Bylaws to clarify the procedure
regarding the removal of directors, consistent with the General
Corporation Law of the State of Delaware.
Article III Section 13 of the Bylaws is amended by the Amendment
to read as follows, with deletions shown by a strike-through and
new text by an underline:
Section 13. Removal. Subject to any limitations imposed by law or
the Certificate of Incorporation, any Director or>the
entire>Board of Directors, or any individual Director,>may
be removed from office at any time only with cause>, with or
without cause,>by the affirmative vote of the holders of at
least two-thirds of the outstanding shares>holders of a
majority of the shares then>entitled to vote at an election of
Directors.
The Company intends to seek approval of the Companys stockholders
at the 2018 Annual Meeting of Stockholders to make similar
changes to its Restated Certificate of Incorporation regarding
the removal of directors.
The foregoing summary is qualified in its entirety by reference
to the Amendment attached hereto as Exhibit 3.1.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits
Exhibit No.
Description
3.1
Amendment No. 1 to the Amended and Restated Bylaws,
effective as of April 5, 2017.

About DIGIRAD CORPORATION (NASDAQ:DRAD)
Digirad Corporation is a provider of diagnostic solutions. The Company’s business is organized into two segments: Diagnostic Services and Diagnostic Imaging. The Company provides in-office nuclear cardiology and ultrasound imaging services. It also provides cardiac event monitoring services to physician practices, hospitals and imaging centers through its Diagnostic Services business segment. The Company sells solid-state gamma cameras for nuclear cardiology and general nuclear medicine applications, as well as provides service on the products it sells through its Diagnostic Imaging business segment. Diagnostic Services also offers remote cardiac event monitoring services, which include provision of a monitor, remote monitoring by registered nurses and monitoring support for its patients and physician customers. Its nuclear cameras feature detectors based on solid-state technology. Its cameras are used in hospitals, imaging centers, physician offices, and by mobile service providers. DIGIRAD CORPORATION (NASDAQ:DRAD) Recent Trading Information
DIGIRAD CORPORATION (NASDAQ:DRAD) closed its last trading session 00.00 at 4.95 with 110,598 shares trading hands.

Exit mobile version